Federal and state healthcare policy changes affecting access, benefits, eligibility, and care delivery.
CMS says some Medicaid enrollees may be exempt from new 80-hour work rules because of medical frailty. Here’s what the rule says, what the June 29 correction changed, and what still depends on your state.
Starting July 1, 2026, some people with Medicare Part D can get certain GLP-1 weight-loss drugs for a fixed $50 monthly copay through a temporary federal program. Here’s who may qualify, which drugs are included, how prior authorization works, and what the $50 price does not do.
A new federal Medicaid work rule starts in 2026 and states generally must enforce it by January 1, 2027, but it will not apply to every enrollee. Here is who may be covered, who may be exempt, and why paperwork may matter as much as the 80-hour rule.
Not everyone on Medicaid will have to meet the new federal 80-hour monthly requirement. Here is who the rule mainly targets, who may be exempt, when states can begin, and what people can do now to protect coverage.
A new federal Medicaid rule says certain adults will have to show 80 hours a month of work, school, community service, or other qualifying activity to keep coverage, generally starting January 1, 2027. But the rule has many exemptions, and some of the biggest risks may come from paperwork, verification, and state-by-state implementation details that are still developing.
CMS’s June 2026 interim final rule sets new Medicaid community-engagement requirements for some adults, but many people may be exempt. Here’s who is likely excluded, where paperwork could still cause problems, and what readers should know before state rollouts begin in 2027.
Usually not. The new federal rule applies to certain Medicaid expansion adults, not every Medicaid enrollee. But if you are in the affected group, paperwork, renewal timing, and proof of an exemption could matter just as much as the 80-hour standard.
A new federal Medicaid rule sets 2027 work-reporting standards for some adults in expansion coverage, but many people are exempt and state systems may differ.
Hospitals must now meet updated federal price-transparency requirements that took effect in 2026, but the numbers still won’t tell every patient what they will owe. Here’s how the new files and shoppable-service displays can help — and where the limits remain.
CMS has proposed new rules that could make drug prior authorization decisions faster and more transparent for many patients and clinicians. The proposal would set 24-hour deadlines for urgent requests and 72-hour deadlines for standard requests, but it is not final yet.
CMS and HHS have announced new rural health funding, while CMS is also moving ahead with hospital price transparency updates and a proposed rule on Medicaid managed care and fee-for-service payments. For patients, the biggest near-term effects could show up in access, provider payments, and how clearly hospitals must post prices, though details will vary by state, plan, and facility.
CMS has proposed new electronic prior-authorization rules for drugs that could shorten some approval waits, but the change is not final. The plan would still need public comments, a final rule, and plan-by-plan implementation before patients see any effect.
CMS has launched a five-year rural health program that will send money to every state starting in 2026. The key question for patients is whether states use the funds to improve local care, shorten travel times, and strengthen services people can actually reach.
CMS has proposed new prior-authorization and interoperability rules that could speed up drug coverage decisions for some plans if finalized. The main promise is less waiting and more transparency — but the change is still only a proposal, and details can still change after public comment.
HHS has given covered health providers one more year to make websites and mobile apps meet federal accessibility standards under Section 504. For patients, that could mean some access fixes arrive more slowly than expected, even as organizations keep working toward compliance.
Many people shopping for 2026 coverage on the Health Insurance Marketplace will see higher premiums because enhanced federal premium tax credits expired at the end of 2025. The size of the increase depends on income, age, household size, state, and the plan you choose.
CMS has proposed new rules aimed at speeding up prior authorization for prescription drugs and making the process more transparent for patients and clinicians. The changes are not final yet, but they could affect several major coverage groups if adopted.
CMS has already finalized some prior authorization changes, and it has also proposed new drug-related rules that are not final yet. Here’s how the new timeline works, who may feel it, and what to do if care is delayed or denied.
CMS and FDA have announced RAPID, a new pathway meant to shorten Medicare coverage decisions for certain breakthrough medical devices. The change could help some patients get access sooner, but it applies only to a narrow set of devices and still depends on formal federal review.
CMS has proposed extending its electronic prior-authorization rules to prescription drugs, with comments open through June 15, 2026. If finalized, the change could reduce paperwork and speed some decisions, but prior authorization would still exist and results could vary by plan.
CMS has proposed shorter deadlines and more electronic processing for prescription-drug prior authorizations in several federal health coverage programs. The plan would not end prior authorization, but it could reduce delays and improve transparency around denials and appeals.
CMS has proposed a new rule that would expand electronic prior authorization to drugs and add faster decision timelines for some plans. The change is not final yet, and the details could still change after public comment closes on June 15, 2026.
End of content
End of content